BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16126914)

  • 1. Serotonin, L-tryptophan, and tryptamine are effective inhibitors of the amino acid transport system PAT1.
    Metzner L; Kottra G; Neubert K; Daniel H; Brandsch M
    FASEB J; 2005 Sep; 19(11):1468-73. PubMed ID: 16126914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel bifunctionality: PAT1 and PAT2 mediate electrogenic proton/amino acid and electroneutral proton/fatty acid symport.
    Foltz M; Boll M; Raschka L; Kottra G; Daniel H
    FASEB J; 2004 Nov; 18(14):1758-60. PubMed ID: 15345686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal drug transport via the proton-coupled amino acid transporter PAT1 (SLC36A1) is inhibited by Gly-X(aa) dipeptides.
    Frølund S; Langthaler L; Kall MA; Holm R; Nielsen CU
    Mol Pharm; 2012 Sep; 9(9):2761-9. PubMed ID: 22853447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of a proton gradient on the transport kinetics of the H+/amino acid cotransporter PAT1 in Caco-2 cells.
    Metzner L; Brandsch M
    Eur J Pharm Biopharm; 2006 Jul; 63(3):360-4. PubMed ID: 16531028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate specificity of the amino acid transporter PAT1.
    Metzner L; Neubert K; Brandsch M
    Amino Acids; 2006 Sep; 31(2):111-7. PubMed ID: 16699824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate recognition by the mammalian proton-dependent amino acid transporter PAT1.
    Boll M; Foltz M; Anderson CM; Oechsler C; Kottra G; Thwaites DT; Daniel H
    Mol Membr Biol; 2003; 20(3):261-9. PubMed ID: 12893527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport of pharmacologically active proline derivatives by the human proton-coupled amino acid transporter hPAT1.
    Metzner L; Kalbitz J; Brandsch M
    J Pharmacol Exp Ther; 2004 Apr; 309(1):28-35. PubMed ID: 14718599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid derivatives are substrates or non-transported inhibitors of the amino acid transporter PAT2 (slc36a2).
    Edwards N; Anderson CM; Gatfield KM; Jevons MP; Ganapathy V; Thwaites DT
    Biochim Biophys Acta; 2011 Jan; 1808(1):260-70. PubMed ID: 20691150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of bidirectional H+ and substrate transport by the proton-dependent amino acid symporter PAT1.
    Foltz M; Mertl M; Dietz V; Boll M; Kottra G; Daniel H
    Biochem J; 2005 Mar; 386(Pt 3):607-16. PubMed ID: 15504109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transport of the areca nut alkaloid arecaidine by the human proton-coupled amino acid transporter 1 (hPAT1).
    Voigt V; Laug L; Zebisch K; Thondorf I; Markwardt F; Brandsch M
    J Pharm Pharmacol; 2013 Apr; 65(4):582-90. PubMed ID: 23488788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate specificity and functional characterisation of the H+/amino acid transporter rat PAT2 (Slc36a2).
    Kennedy DJ; Gatfield KM; Winpenny JP; Ganapathy V; Thwaites DT
    Br J Pharmacol; 2005 Jan; 144(1):28-41. PubMed ID: 15644866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The orally active antihyperglycemic drug beta-guanidinopropionic acid is transported by the human proton-coupled amino acid transporter hPAT1.
    Metzner L; Dorn M; Markwardt F; Brandsch M
    Mol Pharm; 2009; 6(3):1006-11. PubMed ID: 19358571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and function of the amino acid transporter PAT1 (slc36a1) from rabbit and discrimination between transport via PAT1 and system IMINO in renal brush-border membrane vesicles.
    Miyauchi S; Abbot EL; Zhuang L; Subramanian R; Ganapathy V; Thwaites DT
    Mol Membr Biol; 2005; 22(6):549-59. PubMed ID: 16373326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vigabatrin transport across the human intestinal epithelial (Caco-2) brush-border membrane is via the H+ -coupled amino-acid transporter hPAT1.
    Abbot EL; Grenade DS; Kennedy DJ; Gatfield KM; Thwaites DT
    Br J Pharmacol; 2006 Feb; 147(3):298-306. PubMed ID: 16331283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Hydroxy-L-tryptophan alters gaboxadol pharmacokinetics in rats: involvement of PAT1 and rOat1 in gaboxadol absorption and elimination.
    Larsen M; Holm R; Jensen KG; Sveigaard C; Brodin B; Nielsen CU
    Eur J Pharm Sci; 2010 Jan; 39(1-3):68-75. PubMed ID: 19900542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of ionic transport and ATPase activities by serotonin analogues in the isolated toad lens.
    Candia OA; Lanzetta PA; Alvarez LJ; Gaines W
    Biochim Biophys Acta; 1980 Nov; 602(2):389-400. PubMed ID: 6252964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estradiol inhibits the activity of proton-coupled amino acid transporter PAT1 expressed in Xenopus oocytes.
    Shan L; Yang Y; Wang J; Zuo J; Dong X; Li C; Li D
    Eur J Pharmacol; 2012 Nov; 695(1-3):34-9. PubMed ID: 22975709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transport characteristics of differently charged cephalosporin antibiotics in oocytes expressing the cloned intestinal peptide transporter PepT1 and in human intestinal Caco-2 cells.
    Wenzel U; Gebert I; Weintraut H; Weber WM; Clauss W; Daniel H
    J Pharmacol Exp Ther; 1996 May; 277(2):831-9. PubMed ID: 8627565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of CYP1A2 enzyme activity by indoleamines: inhibition by serotonin and tryptamine.
    Agúndez JA; Gallardo L; Martínez C; Gervasini G; Benítez J
    Pharmacogenetics; 1998 Jun; 8(3):251-8. PubMed ID: 9682270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proton-coupled amino acid transporter, SLC36A1 (hPAT1), transports Gly-Gly, Gly-Sar and other Gly-Gly mimetics.
    Frølund S; Holm R; Brodin B; Nielsen CU
    Br J Pharmacol; 2010 Oct; 161(3):589-600. PubMed ID: 20880398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.